GeneDx Holdings Corp. Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale
GeneDx Holdings Corp. (WGS) reported Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale of $20.48 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities · last filed 2026-08-03
- GeneDx Holdings Corp. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for the quarter ending 2026-06-30 was $11.97M, a 6.26% decline year-over-year.
- GeneDx Holdings Corp. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for the quarter ending 2026-03-31 was $8.50M, a 38.98% decline year-over-year.
- GeneDx Holdings Corp. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for the quarter ending 2025-12-31 was $10.02M, a 37.81% decline year-over-year.
- GeneDx Holdings Corp. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for the quarter ending 2025-09-30 was $7.25M, a 55.34% decline year-over-year.
- GeneDx Holdings Corp. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for fiscal 2025 was $43.97M, a 7.09% increase from fiscal 2024.
- GeneDx Holdings Corp. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for fiscal 2024 was $41.06M, a 131.13% increase from fiscal 2023.
- GeneDx Holdings Corp. proceeds from maturities, prepayments and calls of debt securities, available-for-sale for fiscal 2023 was $17.77M.
| Period end | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 3 month | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 6 month | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 9 month | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 12 month |
|---|---|---|---|---|
| 2026-06-30 | $11.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $20.48M 10-Q · filed 2026-08-03 | $30.49M derived: sum of 3 quarters · filed 2026-08-03 | $37.74M derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | $8.50M 10-Q · filed 2026-05-04 | $18.52M derived: sum of 2 quarters · filed 2026-05-04 | $25.77M derived: sum of 3 quarters · filed 2026-05-04 | $38.54M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | $10.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $17.27M derived: sum of 2 quarters · filed 2026-02-23 | $30.04M derived: sum of 3 quarters · filed 2026-08-03 | $43.97M 10-K · filed 2026-02-23 |
| 2025-09-30 | $7.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $20.02M derived: sum of 2 quarters · filed 2026-08-03 | $33.95M 10-Q · filed 2025-10-28 | $50.06M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | $12.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $26.70M 10-Q · filed 2026-08-03 | $42.81M derived: sum of 3 quarters · filed 2026-08-03 | $59.05M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | $13.93M 10-Q · filed 2026-05-04 | $30.04M derived: sum of 2 quarters · filed 2026-05-04 | $46.27M derived: sum of 3 quarters · filed 2026-05-04 | $49.13M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $16.11M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $32.34M derived: sum of 2 quarters · filed 2026-02-23 | $35.20M derived: sum of 3 quarters · filed 2026-02-23 | $41.06M 10-K · filed 2026-02-23 |
| 2024-09-30 | $16.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $19.10M derived: sum of 2 quarters · filed 2025-10-28 | $24.95M 10-Q · filed 2025-10-28 | $26.05M derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-06-30 | $2.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $8.72M 10-Q · filed 2025-07-29 | $9.82M derived: sum of 3 quarters · filed 2026-02-23 | $26.48M derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-03-31 | $5.86M 10-Q · filed 2025-04-30 | $6.96M derived: sum of 2 quarters · filed 2026-02-23 | $23.62M derived: sum of 3 quarters · filed 2026-02-23 | $23.62M derived: sum of 4 quarters · filed 2026-02-23 |
| 2023-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $17.77M derived: sum of 2 quarters · filed 2026-02-23 | $17.77M derived: sum of 3 quarters · filed 2026-02-23 | $17.77M 10-K · filed 2026-02-23 |
| 2023-09-30 | $16.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $16.66M derived: sum of 2 quarters · filed 2024-10-29 | $16.66M 10-Q · filed 2024-10-29 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | $0.00 10-Q · filed 2024-07-30 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-04-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |